EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human umbilical cord mesenchymal stem cells decellular matrix alleviates chondrocyte senescence by inhibiting the STING-NF-κB pathway

Yuelong Zhang, Xunshan Ren, Huangming Zhuang, Huajie Li, Miradj Siddick Adam, Rongling Feng, Junming Zhu, Panghu Zhou iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0325704 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Yuelong Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: NF-kappa B, Mesenchymal Stem Cells, Cellular Senescence, Chondrocytes. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Wuhan University Education and Development Foundation, the Fundamental Research Funds for the Central Universities, the Cross-Innovation Talent Program of Renmin Hospital of Wuhan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteoarthritis (OA), characterized by synovial inflammation, articular cartilage degeneration, and structural changes of subchondral bone and periarticular tissues, represents a major unmet clinical challenge. Targeting senescent chondrocytes has emerged as a promising therapeutic strategy of OA. Human umbilgratical cord mesenchymal stem cells (hUCMSCs) have shown potential in OA treatment through paracrine mechanisms, but their clinical translation is limited by challenges in cell viability control and safety concerns. hUCMSCs decellular extracellular matrix (hUCMSCs-dECM) can target senescent chondrocytes to alleviate senescence in OA. Stimulator of interferon gene (STING) can promote chondrocyte senescence in OA through the activation of NF-κB signaling, and inhibition of STING may provide a novel approach for OA treatment. Here, we demonstrated that hUCMSCs-dECM attenuated chondrocyte senescence in vivo and in vitro by inhibiting the STING-NF-κB pathway, which would provide a novel approach for OA treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-kappa BMesenchymal Stem CellsCellular SenescenceChondrocytesUmbilical CordMembrane ProteinsExtracellular MatrixHumansSignal TransductionAnimalsOsteoarthritisMiceCells, CulturedMesenchymal Stem Cell TransplantationSTING Protein

Substanzen

NF-kappa BMembrane ProteinsSTING1 protein, humanSTING Protein

Autor:innen und Institutionen

  • Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, China.

ORCID-Profile: Panghu Zhou

Förderung

  • the Wuhan University Education and Development Foundation
  • the Fundamental Research Funds for the Central Universities
  • the Cross-Innovation Talent Program of Renmin Hospital of Wuhan University
  • National Natural Science Foundation of China

Zitieren

APA

Zhang, Y., Ren, X., Zhuang, H., Li, H., Adam, M. S., Feng, R., Zhu, J., & Zhou, P. (2025). Human umbilical cord mesenchymal stem cells decellular matrix alleviates chondrocyte senescence by inhibiting the STING-NF-κB pathway. PLOS One. https://doi.org/10.1371/journal.pone.0325704

Vancouver

Zhang Y, Ren X, Zhuang H, Li H, Adam MS, Feng R, et al. Human umbilical cord mesenchymal stem cells decellular matrix alleviates chondrocyte senescence by inhibiting the STING-NF-κB pathway. PLOS One. 2025. doi:10.1371/journal.pone.0325704

BibTeX
@article{Zhang2025,
  author = {Zhang, Yuelong and Ren, Xunshan and Zhuang, Huangming and Li, Huajie and Adam, Miradj Siddick and Feng, Rongling and Zhu, Junming and Zhou, Panghu},
  title = {Human umbilical cord mesenchymal stem cells decellular matrix alleviates chondrocyte senescence by inhibiting the STING-NF-κB pathway},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0325704}
}
Kostenlos starten →